Bessette, US
Colette I. Bessette, Chuluota, FL US
Patent application number | Description | Published |
---|---|---|
20080243928 | Human Factors Process Failure Modes and Effects Analysis (HF PFMEA) Software Tool - Methods, computer-readable media, and systems for automatically performing Human Factors Process Failure Modes and Effects Analysis for a process are provided. At least one task involved in a process is identified, where the task includes at least one human activity. The human activity is described using at least one verb. A human error potentially resulting from the human activity is automatically identified, the human error is related to the verb used in describing the task. A likelihood of occurrence, detection, and correction of the human error is identified. The severity of the effect of the human error is identified. The likelihood of occurrence, and the severity of the risk of potential harm is identified. The risk of potential harm is compared with a risk threshold to identify the appropriateness of corrective measures. | 10-02-2008 |
Jason Bessette, Portland, OR US
Patent application number | Description | Published |
---|---|---|
20130326205 | DETERMINISTIC CLOCK CROSSING - Techniques and apparatuses for clock crossing. A reset circuit on a first die generates a forwarded FIFO reset signal synchronous to a reference clock that identifies a single edge. A clock generation circuit on the first die generates the reference clock signal. Control circuitry on the first die generates a forwarded signal, synchronous to the forwarded clock that identifies a forwarded clock edge with fixed timing relationship to the forwarded clock edge a transmit PLL locks to the single reference edge. A phase locked loop (PLL) on a second die is coupled to receive the reference clock signal, the PLL to generate a local clock signal. A circular FIFO with a write pointer advanced by the forwarded clock and a read pointer advanced by the local clock. | 12-05-2013 |
20140189241 | Method and Apparatus to Write Modified Cache Data To A Backing Store While Retaining Write Permissions - A method is described that includes performing the following for a transactional operation in response to a request from a processing unit that is directed to a cache identifying a cache line. Reading the cache line, and, if the cache line is in a Modified cache coherency protocol state, forwarding the cache line to circuitry that will cause the cache line to be written to deeper storage, and, changing another instance of the cache line that is available to the processing unit for the transactional operation to an Exclusive cache coherency state | 07-03-2014 |
Jason A. Bessette, Portland, OR US
Patent application number | Description | Published |
---|---|---|
20140006698 | Hybrid Cache State And Filter Tracking Of Memory Operations During A Transaction | 01-02-2014 |
Jon Bessette, Tewksbury, MA US
Patent application number | Description | Published |
---|---|---|
20120297772 | SYSTEMS AND METHODS FOR EFFICIENT TWO-PHASE HEAT TRANSFER IN COMPRESSED-AIR ENERGY STORAGE SYSTEMS - In various embodiments, foam is compressed to store energy and/or expanded to recover energy. | 11-29-2012 |
20130074485 | SYSTEMS AND METHODS FOR FOAM-BASED HEAT EXCHANGE DURING ENERGY STORAGE AND RECOVERY USING COMPRESSED GAS - In various embodiments, foam is compressed to store energy and/or expanded to recover energy. | 03-28-2013 |
20130074488 | SYSTEMS AND METHODS FOR FOAM-BASED HEAT EXCHANGE DURING ENERGY STORAGE AND RECOVERY USING COMPRESSED GAS - In various embodiments, foam is compressed to store energy and/or expanded to recover energy. | 03-28-2013 |
20130074940 | SYSTEMS AND METHODS FOR FOAM-BASED HEAT EXCHANGE DURING ENERGY STORAGE AND RECOVERY USING COMPRESSED GAS - In various embodiments, foam is compressed to store energy and/or expanded to recover energy. | 03-28-2013 |
20130074941 | SYSTEMS AND METHODS FOR FOAM-BASED HEAT EXCHANGE DURING ENERGY STORAGE AND RECOVERY USING COMPRESSED GAS - In various embodiments, foam is compressed to store energy and/or expanded to recover energy. | 03-28-2013 |
20130074949 | SYSTEMS AND METHODS FOR FOAM-BASED HEAT EXCHANGE DURING ENERGY STORAGE AND RECOVERY USING COMPRESSED GAS - In various embodiments, foam is compressed to store energy and/or expanded to recover energy. | 03-28-2013 |
20130145764 | SYSTEMS AND METHODS FOR EFFICIENT TWO-PHASE HEAT TRANSFERIN COMPRESSED-AIR ENERGY STORAGE SYSTEMS - In various embodiments, foam is compressed to store energy and/or expanded to recover energy. | 06-13-2013 |
20130336721 | FLUID STORAGE IN COMPRESSED-GAS ENERGY STORAGE AND RECOVERY SYSTEMS - In various embodiments, lined underground reservoirs and/or insulated pipeline vessels are utilized for storage of compressed fluid in conjunction with energy storage and recovery systems. | 12-19-2013 |
20140000251 | SYSTEMS AND METHODS FOR EFFICIENT TWO-PHASE HEAT TRANSFER IN COMPRESSED-AIR ENERGY STORAGE SYSTEMS | 01-02-2014 |
20140013735 | FLUID STORAGE IN COMPRESSED-GAS ENERGY STORAGE AND RECOVERY SYSTEMS - In various embodiments, lined underground reservoirs and/or insulated pipeline vessels are utilized for storage of compressed fluid in conjunction with energy storage and recovery systems. | 01-16-2014 |
Jonathan T. Bessette, Montpelier, VT US
Patent application number | Description | Published |
---|---|---|
20140254620 | High-Concentration Active Doping in Semiconductors and Semiconductor Devices Produced by Such Doping - In a method of forming a photonic device, a first silicon electrode is formed, and then a germanium active layer is formed on the first silicon electrode while including n-type dopant atoms in the germanium layer, during formation of the layer, to produce a background electrical dopant concentration that is greater than an intrinsic dopant concentration of germanium. A second silicon electrode is then formed on a surface of the germanium active layer. The formed germanium active layer is doped with additional dopant for supporting an electrically-pumped guided mode as a laser gain medium with an electrically-activated n-type electrical dopant concentration that is greater than the background dopant concentration to overcome electrical losses of the photonic device. | 09-11-2014 |
Jonathan T. Bessette, Essex Junction, VT US
Patent application number | Description | Published |
---|---|---|
20090027038 | Systems And Methods That Detect Changes In Incident Optical Radiation - Systems, methods and sensors detect changes in incident optical radiation. Current is driven through one or more active areas of a detector while the incident optical radiation illuminates the active areas. Voltage is sensed across one or more of the active areas, a change in the voltage being indicative of the changes in incident optical radiation. | 01-29-2009 |
20110139964 | Systems And Methods That Detect Changes In Incident Optical Radiation - Systems, methods and sensors detect changes in incident optical radiation. Voltage is applied across one or more active areas of a detector while the incident optical radiation illuminates the active areas. Current is sensed across one or more of the active areas, a change in the current being indicative of the changes in incident optical radiation. | 06-16-2011 |
Luc Bessette, Montreal, CA US
Patent application number | Description | Published |
---|---|---|
20110060762 | SYSTEM AND METHOD FOR ELECTRONICALLY MANAGING MEDICAL DATA FILES - A network server arrangement including a processor with a machine readable storage encoded with software for execution by the processor. The network server arrangement is responsive to requests to access a medical record of an individual and generates summary medical record data including summary information having a plurality of data elements associated with the individual, at least one of the data elements conveying medical information about the individual, and a pointers component including at least one pointer pointing to a network location containing importable medical information in connection with the individual that is not contained in the summary information component. The pointer includes a machine readable address part for processing by the client, allowing the client to import the medical information from the network location, and a label part for displaying to a user the nature of the medical information residing at the network location. | 03-10-2011 |
Paul H. Bessette, Camarillo, CA US
Patent application number | Description | Published |
---|---|---|
20100113303 | Polypeptide Display Libraries and Methods of Making and Using Thereof - Disclosed herein are expression vectors which display a passenger polypeptide on the outer surface of a biological entity. As disclosed herein the displayed passenger polypeptide is capable of interacting or binding with a given ligand. Also disclosed are methods of making and using the expression vectors. N/C terminal fusion expression vectors and methods of making and using are also disclosed. | 05-06-2010 |
20100189651 | MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF - The present disclosure provides modified antibodies which contain an antibody or antibody fragment (AB) modified with a masking moiety (MM). Such modified antibodies can be further coupled to a cleavable moiety (CM), resulting in activatable antibodies (AAs), wherein the CM is capable of being cleaved, reduced, photolysed, or otherwise modified. AAs can exhibit an activatable conformation such that the AB is more accessible to a target after, for example, removal of the MM by cleavage, reduction, or photolysis of the CM in the presence of an agent capable of cleaving, reducing, or photolysing the CM. The disclosure further provides methods of making and using such modified antibodies and activatable antibodies. | 07-29-2010 |
20100221212 | PROPROTEINS AND METHODS OF USE THEREOF - The present disclosure provides for proprotein and activatable proprotein compositions. A proprotein contains a functional protein (i.e. a full length protein or functional fragment thereof) which is coupled to a peptide mask that inhibits the binding of the functional protein to its target or binding partner. An activatable proprotein contains a functional protein coupled to a peptide mask, and further coupled to an activatable linker, wherein in an non-activated state, the peptide mask inhibits binding of the functional protein to its target or binding partner and in an activated state the peptide mask does not inhibit binding of the functional protein to its target or binding partner. Proproteins can provide for reduced toxicity and adverse side effects that could otherwise result from binding of a functional protein at non-treatment sites if it were not inhibited from binding its binding partner. Proproteins can further provide improved biodistribution characteristics. Proproteins containing a peptide mask can display a longer in vivo or serum half-life than the corresponding functional protein not containing a peptide mask. The disclosure further provides methods of screening for, making, and using these proproteins. | 09-02-2010 |
20120149061 | Modified Antibody Compositions, Methods of Making and Using Thereof - The present disclosure provides modified antibodies which contain an antibody or antibody fragment (AB) modified with a masking moiety (MM). Such modified antibodies can be further coupled to a cleavable moiety (CM), resulting in activatable antibodies (AAs), wherein the CM is capable of being cleaved, reduced, photolysed, or otherwise modified. AAs can exhibit an activatable conformation such that the AB is more accessible to a target after, for example, removal of the MM by cleavage, reduction, or photolysis of the CM in the presence of an agent capable of cleaving, reducing, or photolysing the CM. The disclosure further provides methods of making and using such modified antibodies and activatable antibodies. | 06-14-2012 |
20120207756 | Modified Antibody Compositions, Methods of Making and Using Thereof - The present disclosure provides modified antibodies which contain an antibody or antibody fragment (AB) modified with a masking moiety (MM). Such modified antibodies can be further coupled to a cleavable moiety (CM), resulting in activatable antibodies (AAs), wherein the CM is capable of being cleaved, reduced, photolysed, or otherwise modified. AAs can exhibit an activatable conformation such that the AB is more accessible to a target after, for example, removal of the MM by cleavage, reduction, or photolysis of the CM in the presence of an agent capable of cleaving, reducing, or photolysing the CM. The disclosure further provides methods of making and using such modified antibodies and activatable antibodies. | 08-16-2012 |
20130101555 | Proproteins and Methods of Use Thereof - The present disclosure provides for proprotein and activatable proprotein compositions. A proprotein contains a functional protein (i.e. a full length protein or functional fragment thereof) which is coupled to a peptide mask that inhibits the binding of the functional protein to its target or binding partner. An activatable proprotein contains a functional protein coupled to a peptide mask, and further coupled to an activatable linker, wherein in an non-activated state, the peptide mask inhibits binding of the functional protein to its target or binding partner and in an activated state the peptide mask does not inhibit binding of the functional protein to its target or binding partner. Proproteins can provide for reduced toxicity and adverse side effects that could otherwise result from binding of a functional protein at non-treatment sites if it were not inhibited from binding its binding partner. Proproteins can further provide improved biodistribution characteristics. Proproteins containing a peptide mask can display a longer in vivo or serum half-life than the corresponding functional protein not containing a peptide mask. The disclosure further provides methods of screening for, making, and using these proproteins. | 04-25-2013 |
20130210673 | Polypeptide Display Libraries and Methods of Making and Using Thereof - Disclosed herein are expression vectors which display a passenger polypeptide on the outer surface of a biological entity. As disclosed herein the displayed passenger polypeptide is capable of interacting or binding with a given ligand. Also disclosed are methods of making and using the expression vectors. N/C terminal fusion expression vectors and methods of making and using are also disclosed. | 08-15-2013 |
20130309230 | Modified Antibody Compositions, Methods of Making and Using Thereof - The present disclosure provides modified antibodies which contain an antibody or antibody fragment (AB) modified with a masking moiety (MM). Such modified antibodies can be further coupled to a cleavable moiety (CM), resulting in activatable antibodies (AAs), wherein the CM is capable of being cleaved, reduced, photolysed, or otherwise modified. AAs can exhibit an activatable conformation such that the AB is more accessible to a target after, for example, removal of the MM by cleavage, reduction, or photolysis of the CM in the presence of an agent capable of cleaving, reducing, or photolysing the CM. The disclosure further provides methods of making and using such modified antibodies and activatable antibodies. | 11-21-2013 |
20140010810 | Anti-Jagged 1/Jagged 2 Cross-Reactive Antibodies, Activatable Anti-Jagged Antibodies And Methods Of Use Thereof - This invention relates generally to the generation of antibodies, e.g., monoclonal antibodies including fully human monoclonal antibodies, that recognize Jagged 1 and/or Jagged 2, to antibodies, e.g., monoclonal antibodies including fully human antibodies that recognize Jagged 1 and/or Jagged 2, and nucleic acid molecules that encode antibodies, e.g., nucleic acid molecules that encode monoclonal antibodies including fully human cross-reactive antibodies that recognize both Jagged 1 and Jagged 2, and to methods of making the anti-Jagged antibodies and methods of using the anti-Jagged antibodies as therapeutics, prophylactics, and diagnostics. The invention also relates generally to activatable antibodies that include a masking moiety (MM), a cleavable moiety (CM), and an antibody (AB) that specifically bind to Jagged 1 and Jagged 2, and to methods of making and using these activatable anti-Jagged antibodies in a variety of therapeutic, diagnostic and prophylactic indications. | 01-09-2014 |
20140024810 | Modified Antibody Compositions, Methods of Making and Using Thereof - The present disclosure provides modified antibodies which contain an antibody or antibody fragment (AB) modified with a masking moiety (MM). Such modified antibodies can be further coupled to a cleavable moiety (CM), resulting in activatable antibodies (AAs), wherein the CM is capable of being cleaved, reduced, photolysed, or otherwise modified. AAs can exhibit an activatable conformation such that the AB is more accessible to a target after, for example, removal of the MM by cleavage, reduction, or photolysis of the CM in the presence of an agent capable of cleaving, reducing, or photolysing the CM. The disclosure further provides methods of making and using such modified antibodies and activatable antibodies. | 01-23-2014 |
Russell R. Bessette, Mattapoisett, MA US
Patent application number | Description | Published |
---|---|---|
20090266716 | Method of fabricating a bipolar electrode for use in a semi fuel cell - A bipolar electrode fabricated with a combination of materials that will physically separate the catholyte from the metal anode of the electrode while providing high electrical conductivity between the metal anode and the catalyst cathode. This is accomplished by layering the catalyst cathode over a composite of conductive adhesive and conductive foil that is then affixed to the metal anode. | 10-29-2009 |
20090282898 | Method for quantitative determination of hydrogen peroxide using potentiometric titration - An electrochemical potentiometric titration method that entails titration of a known volume of a catholyte containing an unknown amount of hydrogen peroxide in a titration cell having two electrodes, a platinum working electrode and a silver/silver chloride reference electrode. A known concentration of a titrant is added to the catholyte in the titration cell. Simultaneously, as the titrant is added the potential between the working electrode and the reference electrode is monitored. The point at which all of the hydrogen peroxide has been consumed is signaled when the cell potential changes abruptly. Since the concentration of the titrant is already known, the amount of titrant added (concentration multiplied by volume) is directly related to the amount of hydrogen peroxide consumed. The concentration of hydrogen peroxide is calculated from the volume of catholyte and the moles of hydrogen peroxide. | 11-19-2009 |
Russell W. Bessette, Buffalo, NY US
Patent application number | Description | Published |
---|---|---|
20100312202 | Wound Treatment Apparatus - A bandage has a first sheet overlying a wound and located adjacent to it and a top sheet overlying the first sheet. The first sheet has a plurality of discrete passageways overlying the wound and adapted to communicate negative pressure established by a negative pressure source to the wound. | 12-09-2010 |
20140025025 | WOUND TREATMENT APPARATUS - A bandage has a first sheet overlying a wound and located adjacent to it and a top sheet overlying the first sheet. The first sheet has a plurality of discrete passageways overlying the wound and adapted to communicate negative pressure established by a negative pressure source to the wound. | 01-23-2014 |
Russell W. Bessette, Orchard Park, NY US
Patent application number | Description | Published |
---|---|---|
20090024006 | Method of appraising a mammal's health - An improved method of appraising a mammal's health includes the steps of: measuring the values of a plurality of factors indicative of different health parameters at a first time; normalizing the measured values of said factors at the first time; and arranging such normalized measured values at said first time in a first sequence; thereby to have said first sequence represent the mammal's health at the first time. The method may include the additional steps of: measuring the values of such plurality of factors at a second time; normalizing the measured values of such factors at the second time; arranging such normalized measured values in a second sequence; and comparing the second sequence with the first sequence or with a similar sequences from a plurality of similar animals recording the same primary afflicting condition. | 01-22-2009 |
Russell W. Bessette, Prospect, KY US
Patent application number | Description | Published |
---|---|---|
20120303381 | SYSTEM AND METHOD FOR SCORING ILLNESS COMPLEXITY TO PREDICT HEALTHCARE COST - A processor-based method for presenting patient test data includes acts of obtaining values of factors indicative of different patient health parameters and operatively associating the values of the factors with a unique identifier in a database borne by a physical computer-readable medium. Using a processor, a Z-score is determined for each factor and absolute values for each Z-score are converted into logarithm values. On a display, a radar graph depicts the Z-scores for the plurality of factors, the radar graph defining at least an arc subdivided into a plurality of sectors, each sector being subdivided into a plurality of arcuate sections, wherein log values are plotted from a center point of the radar graph, with the Z-scores of identified ones of the plurality of factors being representing as highlighted arcuate sections extending from the center point of the radar graph outwardly in correspondence with a magnitude of each Z-score. | 11-29-2012 |
20130144641 | Method of Measuring Healthcare Outcomes - Computer-based methods and systems are presented for measuring the quality of healthcare of an individual and for measuring the quality of care of a healthcare provider. The methods comprise the steps of measuring a plurality of factors a first time and a second time, computing a first and second complexity score based on the Z-scores of the first-time and second-time measured values, and determining a quality based on the complexity scores, costs of treatment, and/or elapsed time of treatment. | 06-06-2013 |
Russell W. Bessette, Prespect, KY US
Patent application number | Description | Published |
---|---|---|
20130144642 | Method of Predicting Healthcare Costs - Computer-based methods and systems are presented for determining an illness complexity score, which can be used to predict the likelihood of high-cost hospitalization and/or to predict the patient's healthcare reimbursement costs. The methods comprise the steps of measuring a plurality of factors of a population of individuals, determining an effect on the healthcare costs of the individuals and a weighting coefficient for each factor, identifying significant factors as complexity variables, and computing illness complexity scores for the population of individuals using the weighting coefficients and complexity variables. The population data may then be used to predict the healthcare costs of a patient by calculating the illness complexity score of the individual. | 06-06-2013 |
Steven Bessette, Johnson City, NY US
Patent application number | Description | Published |
---|---|---|
20130124019 | AIRCRAFT CONTROL APPARATUS AND AIRCRAFT CONTROL SYSTEM - A plurality of control channels each include a power supply, an interface that receives a manipulation signal, an arithmetic processing portion that calculates and generates an operation command signal for actuators based on the manipulation signal, and a signal determination unit that determines a control signal for finally controlling the operation of the actuators and outputs the control signal. The arithmetic processing portions respectively provided in the plurality of control channels have designs different from one another. Each of the signal determination units determines the control signal by receiving a first operation command signal generated by the arithmetic processing portion of the control channel in which that signal determination unit is provided, and a second operation command signal generated in the arithmetic processing portion of another of the control channels, and comparing the first operation command signal and the second operation command signal, and outputs the control signal. | 05-16-2013 |
Steven M. Bessette, Brentwood, TN US
Patent application number | Description | Published |
---|---|---|
20080269177 | PESTICIDAL COMPOSITIONS - Pesticidal compositions containing a pesticidally acceptable carrier, and a synergistic blend of plant essential oils as a pesticidally active ingredient and optionally a synergist, and methods for using same, are disclosed. | 10-30-2008 |
20090263515 | PEST REPELLENT COMPOSITIONS AND METHODS - The invention is directed to a topical insect repellent with extended duration of protection and that was obtained by combining natural and organic plant essential oil compounds. The new natural repellent exhibits the longevity and repellency that is comparable to or better than N,N-diethyl-m-toluamide (DEET), a synthetic compound employed in almost all commercial formulations, while at the same time is more acceptable than DEET, which has an unpleasant odor, imparts a greasy feel to the skin, and carries certain health concerns when used on children. The inventive insect repellent, formulated in a suitable carrier repels and incapacitates flying insects and other pests, such as mosquitoes and other biting flies or insects, thus demonstrating the utility of the novel insect repellent for protecting pets and livestock as well as humans. The invention provides an effective means to repel insects, without having deleterious effects on people, pets or the environment compared with prior insect repellant formulations. The repellant formulation disclosed herein may employ natural or organic active ingredient, e.g., plant essential oil compounds. | 10-22-2009 |
20100120724 | PESTICIDAL COMPOSITIONS - Pesticidal compositions containing a pesticidally acceptable carrier, and a synergistic blend of plant essential oils as a pesticidally active ingredient and optionally a synergist, and methods for using same, are disclosed. | 05-13-2010 |
20100144888 | PESTICIDAL METHODS AND COMPOSITIONS FOR MODULATING GABA RECEPTORS - Methods for using pesticidal compositions containing a pesticidally acceptable carrier, at least one GABA receptor modulator compound as a pesticidally active ingredient and optionally an additional compounds, such as a synergist, and methods for using same. | 06-10-2010 |
20110070322 | PESTICIDAL COMPOSITIONS CONTAINING ROSEMARY OIL AND WINTERGREEN OIL - Pesticidal compositions containing rosemary oil and/or wintergreen oil and methods for using same are disclosed. | 03-24-2011 |
Steven M. Bessette, San Clemente, CA US
Patent application number | Description | Published |
---|---|---|
20130142893 | PESTICIDAL COMPOSITIONS CONTAINING ROSEMARY OIL AND WINTERGREEN OIL - Pesticidal compositions containing rosemary oil and/or wintergreen oil and methods for using same are disclosed. | 06-06-2013 |
Tyler Bessette, Shelton, CT US
Patent application number | Description | Published |
---|---|---|
20120007732 | Rotary Adjustment For Dual Switch Assembly - The present disclosure provides for systems and methods for fabricating sensing and/or control device assemblies, e.g., a dual pressure switch sensing and/or control device, a dual temperature switch sensing and/or control device or the like. More particularly, the present disclosure provides for systems and methods for fabricating sensing and/or control device assemblies (e.g., dual switch sensing and/or control device assemblies) with adjustment features and/or functionalities for switch calibration and/or adjustment. In one embodiment, the present disclosure provides for systems and methods for fabricating sensing and/or control device assemblies (e.g., dual switch sensing and/or control device assemblies) with rotary adjustment features/functionalities wherein the switches of the sensing device may be calibrated or adjusted via the rotary adjustment features/functionalities. | 01-12-2012 |
Tyler Jon Bessette, Milford, CT US
Patent application number | Description | Published |
---|---|---|
20080237307 | Adapter assembly and method of manufacture - The present disclosure provides for a method of welding an adapter fitting to a fitting on a measuring device system. The present disclosure also provides for a measuring device system having a first fitting that includes a stem, a second fitting that defines an opening sized to receive the first fitting, where the second fitting also defines an abutment face, wherein the second fitting is positioned around the first fitting with the abutment face abutting an outward end of the first fitting, and where at least one weld secures the first fitting to the second fitting. | 10-02-2008 |
20090107235 | Case, Window and Gasket For Measuring Device - The present disclosure provides for systems and methods for fabricating measuring devices, e.g., a pressure gauge, thermometer or the like. More particularly, the present disclosure provides for systems and methods for fabricating measuring device assemblies having at least a case, window and gasket, where the measuring device may be assembled in multiple different ways using the same case, window and gasket. | 04-30-2009 |